Lina S. Franco - Publications

Affiliations: 
2013-2016 Chemistry and Biochemistry Arizona State University, Tempe, AZ, United States 

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Christie JD, Appel N, Canter H, Achi JG, Elliott NM, de Matos AL, Franco L, Kilbourne J, Lowe K, Rahman MM, Villa NY, Carmen J, Luna E, Blattman J, McFadden G. Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma. Molecular Therapy Oncolytics. 22: 539-554. PMID 34553039 DOI: 10.1016/j.omto.2021.07.014  0.462
2020 Jazowiecka-Rakus J, Sochanik A, Rusin A, Hadryś A, Fidyk W, Villa N, Rahman MM, Chmielik E, Franco LS, McFadden G. Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma. Molecular Therapy Oncolytics. 18: 335-350. PMID 32775618 DOI: 10.1016/J.Omto.2020.07.003  0.492
2020 Lemos de Matos A, Franco LS, McFadden G. Oncolytic Viruses and the Immune System: The Dynamic Duo. Molecular Therapy. Methods & Clinical Development. 17: 349-358. PMID 32071927 DOI: 10.1016/J.Omtm.2020.01.001  0.467
2020 Villa NY, Franco LS, McFadden G. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer. Methods in Molecular Biology (Clifton, N.J.). 2058: 95-110. PMID 31486033 DOI: 10.1007/978-1-4939-9794-7_6  0.535
2020 Ortegon S, Franco LS, McFadden G, Cordovez J. Mathematical model of oncolytic virotherapy with Myxoma virus infection in cancer cells The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07088  0.456
2017 Franco LS, Holechek SA, Caplan MR, Blattman JN. Sequence-specific detection of different strains of LCMV in a single sample using tentacle probes. Virology Journal. 14: 197. PMID 29029641 DOI: 10.1186/S12985-017-0863-9  0.424
Show low-probability matches.